Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Mesenchymal stem cells
Stem cells
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
IMAT-MSCs
Stem cells
Potential treatment - pre-clinical evidence Experimental Other treatment Sep/23/2022
Convalescent plasma
Stem cells
Emergency use authorization Experimental Antiviral May/16/2022
Tocilizumab
Stem cells
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Hematopoietic stem cells
Stem cells
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/06/2021
hACE21−740-Fc
Stem cells
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2021
scFv-IL6R-Fc
Stem cells
Potential treatment - theoretical effect Experimental Other treatment Jun/11/2021
Menstrual blood-derived stem cells
Stem cells
Potential treatment - clinical evidence Experimental Other treatment Mar/06/2021
NSC Ex/Mv
Stem cells
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/18/2020